140 related articles for article (PubMed ID: 15280439)
1. Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier.
Monnaert V; Betbeder D; Fenart L; Bricout H; Lenfant AM; Landry C; Cecchelli R; Monflier E; Tilloy S
J Pharmacol Exp Ther; 2004 Dec; 311(3):1115-20. PubMed ID: 15280439
[TBL] [Abstract][Full Text] [Related]
2. Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier.
Gil ES; Li J; Xiao H; Lowe TL
Biomacromolecules; 2009 Mar; 10(3):505-16. PubMed ID: 19216528
[TBL] [Abstract][Full Text] [Related]
3. Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier.
Tilloy S; Monnaert V; Fenart L; Bricout H; Cecchelli R; Monflier E
Bioorg Med Chem Lett; 2006 Apr; 16(8):2154-7. PubMed ID: 16464592
[TBL] [Abstract][Full Text] [Related]
4. Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier.
Monnaert V; Tilloy S; Bricout H; Fenart L; Cecchelli R; Monflier E
J Pharmacol Exp Ther; 2004 Aug; 310(2):745-51. PubMed ID: 15082751
[TBL] [Abstract][Full Text] [Related]
5. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
6. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
Lu W; Tan YZ; Jiang XG
Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
[TBL] [Abstract][Full Text] [Related]
7. Effect of p-glycoprotein inhibitor combinations on drug efflux from rat brain microvessel endothelial cells.
Yang ZY; Liu GQ
Pharmazie; 2004 Dec; 59(12):952-6. PubMed ID: 15638085
[TBL] [Abstract][Full Text] [Related]
8. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
Lu W; Tan YZ; Hu KL; Jiang XG
Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of glial cells against lipopolysaccharide-mediated blood-brain barrier injury.
Descamps L; Coisne C; Dehouck B; Cecchelli R; Torpier G
Glia; 2003 Apr; 42(1):46-58. PubMed ID: 12594736
[TBL] [Abstract][Full Text] [Related]
10. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.
Boveri M; Berezowski V; Price A; Slupek S; Lenfant AM; Benaud C; Hartung T; Cecchelli R; Prieto P; Dehouck MP
Glia; 2005 Aug; 51(3):187-98. PubMed ID: 15800928
[TBL] [Abstract][Full Text] [Related]
11. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
[TBL] [Abstract][Full Text] [Related]
12. Chlorpyrifos alters functional integrity and structure of an in vitro BBB model: co-cultures of bovine endothelial cells and neonatal rat astrocytes.
Parran DK; Magnin G; Li W; Jortner BS; Ehrich M
Neurotoxicology; 2005 Jan; 26(1):77-88. PubMed ID: 15527875
[TBL] [Abstract][Full Text] [Related]
13. The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model.
Miller F; Fenart L; Landry V; Coisne C; Cecchelli R; Dehouck MP; Buée-Scherrer V
Eur J Neurosci; 2005 Aug; 22(4):835-44. PubMed ID: 16115207
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.
Stamatovic SM; Shakui P; Keep RF; Moore BB; Kunkel SL; Van Rooijen N; Andjelkovic AV
J Cereb Blood Flow Metab; 2005 May; 25(5):593-606. PubMed ID: 15689955
[TBL] [Abstract][Full Text] [Related]
15. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
[TBL] [Abstract][Full Text] [Related]
16. A novel flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2.
Neuhaus W; Lauer R; Oelzant S; Fringeli UP; Ecker GF; Noe CR
J Biotechnol; 2006 Aug; 125(1):127-41. PubMed ID: 16730091
[TBL] [Abstract][Full Text] [Related]
17. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro.
Kraus J; Ling AK; Hamm S; Voigt K; Oschmann P; Engelhardt B
Ann Neurol; 2004 Aug; 56(2):192-205. PubMed ID: 15293271
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells.
Mitchell RW; On NH; Del Bigio MR; Miller DW; Hatch GM
J Neurochem; 2011 May; 117(4):735-46. PubMed ID: 21395585
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.
Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564
[TBL] [Abstract][Full Text] [Related]
20. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
